Clinical Trials Nct-pagina
Clinical Trial Results:
Randomized, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20-mg od, for inhibition of atherosclerosis progression assessed by IVUS (IntraVascular UltraSounds), in overweight patients with clustering risk factors
| Summary | |
EudraCT number | 2004-003929-27 |
Trial protocol | IT ES |
Global completion date | 19 Oct 2007 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 29 Oct 2016 |
First version publication date | 29 Oct 2016 |
Other versions | |
Summary report(s) | EFC5827 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.